Does Tufts Health Plan Cover Viagra?

Prescription access and medication affordability image for Does Tufts Health Plan Cover Viagra?

At a glance

  • Generic sildenafil is listed on most Tufts Health Plan formularies at Tier 2 or Tier 3
  • Brand-name Viagra is generally excluded or placed on a non-preferred specialty tier
  • Prior authorization may be required depending on your specific plan type
  • Quantity limits typically cap fills at 6 to 12 tablets per 30-day period
  • Generic sildenafil costs roughly $1 to $15 per tablet at retail pharmacies with insurance
  • Brand Viagra without coverage runs $70 to $85 per tablet at most U.S. pharmacies
  • Tufts Health Plan operates primarily in Massachusetts and offers HMO, PPO, and Medicare Advantage products
  • A documented diagnosis of erectile dysfunction from a prescribing clinician is standard for coverage
  • Step therapy may require trying sildenafil before tadalafil or other PDE5 inhibitors are approved
  • Appeals and formulary exceptions are available if a covered alternative fails or causes adverse effects

How Tufts Health Plan Handles Erectile Dysfunction Medications

Tufts Health Plan, now operating under the Point32Health umbrella after its 2021 merger with Harvard Pilgrim Health Care, covers prescription medications through a tiered formulary system. Generic sildenafil appears on most Tufts formularies, while brand-name Viagra is typically excluded or classified as non-preferred.

The distinction matters financially. A 2024 IQVIA analysis found that generic medications saved U.S. patients an average of 80% to 85% compared to their brand equivalents [1]. For sildenafil specifically, the generic version entered the U.S. market in December 2017 after Pfizer's patent exclusivity expired. Since then, retail pricing for generic sildenafil 100 mg has dropped to approximately $1 to $15 per tablet at most chain pharmacies, compared to $70 to $85 per tablet for brand Viagra [2].

Tufts organizes its drug formulary into tiers. Tier 1 includes the lowest-cost generics with the smallest copays. Tier 2 covers preferred generics and some preferred brands. Tier 3 and above include non-preferred and specialty drugs with higher cost-sharing. Generic sildenafil sits on Tier 2 or Tier 3 for most Tufts product lines, meaning a copay between $10 and $50 per fill depending on plan design.

Your specific coverage depends on whether you carry a Tufts Health Plan HMO, PPO, Medicare Advantage, or employer-sponsored product. Each uses a slightly different formulary edition.

Prior Authorization and Quantity Limits

Tufts Health Plan may require prior authorization for erectile dysfunction medications depending on your plan category. Prior authorization means your prescribing clinician must submit documentation confirming a medical diagnosis of erectile dysfunction before the pharmacy can process the claim.

The American Urological Association (AUA) guidelines define erectile dysfunction as the consistent inability to attain or maintain an erection sufficient for satisfactory sexual performance [3]. A diagnosis typically involves patient history, validated questionnaires such as the International Index of Erectile Function (IIEF-5), and sometimes laboratory work including testosterone levels and fasting glucose [4].

Quantity limits are common across nearly all commercial insurers for PDE5 inhibitors. A 2019 formulary analysis published in the Journal of Managed Care & Specialty Pharmacy found that 87% of commercial plans imposed quantity limits on sildenafil, with the most frequent cap being 6 tablets per 30-day fill [5]. Tufts follows this pattern. Most Tufts plans allow between 6 and 12 tablets per month, though the exact number varies by product line.

These limits exist partly because PDE5 inhibitors are dosed on an as-needed basis rather than daily (for erectile dysfunction indications). The FDA-approved dosing for sildenafil in erectile dysfunction is 25 mg, 50 mg, or 100 mg taken approximately one hour before sexual activity, with a maximum of one dose per day [6].

Generic Sildenafil vs. Brand Viagra: What Tufts Prefers

Tufts Health Plan, like 92% of U.S. commercial insurers according to a 2023 Pharmacy Benefit Management Institute survey, favors generic medications through formulary design [7]. This preference affects both coverage and cost.

Generic sildenafil contains the same active ingredient, in the same dose, with the same FDA-verified bioequivalence standards as brand Viagra. The FDA requires that generic drugs demonstrate pharmaceutical equivalence and bioequivalence, meaning the rate and extent of absorption fall within 80% to 125% of the reference product in pharmacokinetic studies [8]. In practice, most approved generics fall within 3% to 5% of the brand product's absorption parameters.

If your clinician writes "Viagra" on the prescription, most Tufts pharmacy benefits will automatically substitute the generic unless the prescription specifies "dispense as written" (DAW). A DAW designation for brand Viagra when a generic is available will typically shift the full cost difference to the patient, sometimes exceeding $60 per tablet in additional out-of-pocket expense.

For patients who have a documented medical reason for requiring brand Viagra over generic sildenafil (such as a confirmed adverse reaction to a specific inactive ingredient in the generic formulation), Tufts does offer a formulary exception process.

How to Verify Your Specific Tufts Coverage

Checking your own plan takes about five minutes. The fastest method is Tufts Health Plan's online member portal, where you can search the formulary by drug name and see your plan's tier, quantity limits, and any prior authorization flags.

Three practical steps to confirm coverage:

Step 1: Log into your member portal. Visit the Tufts Health Plan website, manage to the member section, and search "sildenafil" or "Viagra" in the formulary lookup tool. The result will show your plan's tier placement and any restrictions.

Step 2: Call the number on your insurance card. Pharmacy benefit questions route to the prescription coverage team. Ask specifically: "Is sildenafil covered under my formulary, and are there quantity limits or prior authorization requirements?" Write down the reference number for the call.

Step 3: Ask your pharmacist to run a test claim. Before your clinician submits a prior authorization, your pharmacist can process a trial adjudication to see if the claim goes through and what your copay would be. This takes under two minutes and gives you real-time formulary information.

If you have a Tufts Medicare Advantage plan, you can also use the Medicare Plan Finder tool at medicare.gov to search formulary coverage by plan name and drug [9].

What Sildenafil Costs With and Without Tufts Coverage

Cost varies widely depending on coverage status. With Tufts insurance covering generic sildenafil, most members pay $10 to $50 per fill for 6 tablets. Without any insurance, the same fill runs $20 to $90 at major chain pharmacies depending on tablet strength and pharmacy pricing.

A GoodRx market analysis from early 2026 reported the median cash price for 6 tablets of sildenafil 100 mg at $25 across CVS, Walgreens, and Walmart locations in Massachusetts (Tufts' primary service area) [2]. Costco pharmacies consistently price generic sildenafil lower, often under $15 for the same quantity, even without a Costco membership (pharmacy access is legally required to be available to non-members in most states).

For comparison, brand-name Viagra 100 mg carries a wholesale acquisition cost (WAC) of approximately $82 per tablet as of 2026. With no insurance coverage, a 6-tablet fill of brand Viagra costs roughly $490 to $510 at retail [2].

The cost picture changes substantially for patients with high-deductible health plans (HDHPs) through Tufts. Until the annual deductible is met, the patient pays the plan's negotiated rate rather than a flat copay. That negotiated rate for generic sildenafil is typically $8 to $20 per fill, still well below cash price, but higher than a standard copay tier would produce.

Other Erectile Dysfunction Drugs Tufts May Cover

Sildenafil is one of five FDA-approved PDE5 inhibitors for erectile dysfunction. Tufts formularies may cover alternatives depending on your plan.

Tadalafil (generic Cialis): Available in both as-needed (10 mg or 20 mg) and daily (2.5 mg or 5 mg) dosing. Many Tufts plans cover generic tadalafil, sometimes at the same tier as sildenafil. The ENHANCE trial (N=716) demonstrated that tadalafil 20 mg improved erectile function scores by 7.0 points on the IIEF compared to 1.3 points for placebo [10]. Tadalafil's 36-hour duration of action makes it a preferred option for patients wanting more spontaneity.

Vardenafil (generic Levitra): Less commonly prescribed but available as a generic. Coverage varies. The onset of action is approximately 30 to 60 minutes, similar to sildenafil [11].

Avanafil (Stendra): Still under brand protection with no generic available. Most Tufts plans place avanafil on a higher non-preferred tier or exclude it entirely. Its main advantage is a faster onset (approximately 15 minutes) [12].

Step therapy protocols may apply. This means Tufts could require that you try sildenafil first before approving tadalafil or avanafil. A 2021 analysis in Value in Health found that 64% of commercial plans with PDE5 inhibitor coverage used step therapy, most commonly requiring sildenafil as the first-line agent [13].

When Tufts Denies Coverage and How to Appeal

Coverage denials for erectile dysfunction medications happen for several reasons: missing prior authorization, exceeding quantity limits, requesting brand when generic is available, or lacking a documented diagnosis.

If Tufts denies your sildenafil claim, you have the right to appeal. The process follows Massachusetts Division of Insurance regulations and typically involves two internal levels before an external review becomes available [14].

Internal Appeal Level 1: Submit a written appeal within 30 days of the denial. Include your clinician's letter of medical necessity explaining why the medication is appropriate for your diagnosis. Tufts must respond within 30 days for standard appeals or 72 hours for expedited (urgent) appeals.

Internal Appeal Level 2: If the first appeal is denied, request a second-level review. This goes to a different reviewer who was not involved in the initial decision.

External Review: After exhausting internal appeals, Massachusetts law allows you to request an independent external review through the state's Office of Patient Protection. The external reviewer's decision is binding on Tufts [14].

Your clinician's involvement strengthens appeals significantly. A peer-to-peer review, where your prescriber speaks directly with the Tufts medical director handling the case, resolves many denials without a formal written appeal. Ask your clinician's office if they will initiate a peer-to-peer call.

Erectile Dysfunction Prevalence and Treatment Rates

Erectile dysfunction affects a substantial proportion of adult men, with prevalence increasing sharply after age 40. The Massachusetts Male Aging Study (MMAS), one of the largest population-based studies on male sexual health, found that 52% of men aged 40 to 70 reported some degree of erectile dysfunction, with complete ED affecting 9.6% of the cohort [15]. Moderate dysfunction was present in 25.2%, and minimal dysfunction in 17.2%.

Despite effective treatments being available since sildenafil's FDA approval in 1998, treatment rates remain low. A 2020 analysis published in The Journal of Sexual Medicine estimated that only 25% of men with erectile dysfunction receive any pharmacologic treatment [16]. Barriers include cost, stigma, lack of awareness that ED may signal cardiovascular disease, and insurance coverage gaps.

The cardiovascular connection deserves attention. The Princeton III Consensus Panel recommends that men presenting with erectile dysfunction undergo cardiovascular risk assessment, as ED may precede coronary artery disease events by 2 to 5 years [17]. A meta-analysis of 14 prospective studies (N=92,757) found that men with ED had a 44% higher risk of cardiovascular events and a 19% higher risk of all-cause mortality compared to men without ED [18].

This clinical link is one reason why major guidelines, including those from the AUA and the European Association of Urology (EAU), recommend PDE5 inhibitors as first-line pharmacotherapy for erectile dysfunction [3]. Coverage of these medications is not a lifestyle convenience. It is treatment for a recognized medical condition with documented downstream health implications.

Using Sildenafil Safely Under Your Tufts Plan

Once your Tufts plan approves sildenafil, safe use requires awareness of dosing, drug interactions, and contraindications. The starting dose for most men is 50 mg, taken 30 to 60 minutes before anticipated sexual activity [6]. Your clinician may adjust to 25 mg or 100 mg based on efficacy and tolerability.

Absolute contraindications include concurrent use of nitrate medications (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) and riociguat. Combining sildenafil with nitrates can produce severe, potentially fatal hypotension. The FDA black-box interaction warning has been in place since sildenafil's original approval [6].

Alpha-blocker interactions also require caution. Men taking tamsulosin, doxazosin, or other alpha-blockers for benign prostatic hyperplasia should start sildenafil at 25 mg and allow at least 4 hours between doses of the two medications [6].

Common side effects include headache (16%), flushing (10%), dyspepsia (7%), nasal congestion (4%), and visual disturbances such as a blue tint (3%), based on pooled clinical trial data from the original sildenafil registration studies [19]. These effects are generally mild and self-limiting.

Rare but serious adverse events include priapism (an erection lasting longer than 4 hours, requiring emergency treatment), sudden sensorineural hearing loss, and non-arteritic anterior ischemic optic neuropathy (NAION). Report any sudden vision or hearing changes to your clinician immediately [6].

Men with significant renal impairment (creatinine clearance <30 mL/min) or hepatic impairment should start at 25 mg. The same starting dose applies to men over age 65, as sildenafil clearance decreases with age [6].

Frequently asked questions

Does Tufts Health Plan cover Viagra?
Most Tufts Health Plan formularies cover generic sildenafil (the active ingredient in Viagra) but exclude brand-name Viagra. Coverage typically requires a diagnosis of erectile dysfunction and may involve prior authorization or quantity limits of 6 to 12 tablets per month. Check your specific plan formulary through the member portal or by calling the number on your insurance card.
How much does sildenafil cost with Tufts Health Plan?
With Tufts coverage, generic sildenafil copays typically range from $10 to $50 per fill of 6 tablets, depending on your plan tier structure. Without insurance, the same fill costs approximately $20 to $90 at major chain pharmacies. High-deductible plan members pay the negotiated rate (usually $8 to $20) until meeting their deductible.
Does Tufts Health Plan require prior authorization for Viagra or sildenafil?
Some Tufts plan types require prior authorization for erectile dysfunction medications. Your clinician submits documentation confirming an ED diagnosis, and the plan reviews before approving coverage. Check your specific formulary or call Tufts member services to confirm whether your plan has this requirement.
Can I get brand-name Viagra covered by Tufts instead of generic sildenafil?
Brand Viagra is generally excluded from Tufts formularies. If you have a documented medical reason for needing brand over generic (such as an adverse reaction to a generic inactive ingredient), you can request a formulary exception through your clinician. The exception process requires medical justification and may take 7 to 14 days for a decision.
Does Tufts Health Plan cover tadalafil (generic Cialis) for erectile dysfunction?
Many Tufts plans cover generic tadalafil at a similar tier to sildenafil. Tadalafil is available in as-needed doses (10 mg, 20 mg) and a daily dose (2.5 mg, 5 mg). Step therapy rules may require trying sildenafil first before tadalafil is approved. Check your formulary for specific tier placement and restrictions.
What is the quantity limit for sildenafil on Tufts Health Plan?
Most Tufts plans cap sildenafil fills at 6 to 12 tablets per 30-day period for the erectile dysfunction indication. This reflects the as-needed dosing schedule approved by the FDA, with a maximum of one dose per day. If you need a higher quantity, your clinician can submit a quantity limit exception request.
How do I appeal a Tufts Health Plan denial for erectile dysfunction medication?
Submit a written appeal within 30 days of the denial, including a letter of medical necessity from your clinician. Tufts must respond within 30 days. If denied again, request a second-level internal review. After exhausting internal appeals, Massachusetts law provides an external review option through the Office of Patient Protection. A peer-to-peer call between your clinician and the Tufts medical director can also resolve denials.
Does Tufts Medicare Advantage cover sildenafil?
Coverage for sildenafil under Tufts Medicare Advantage plans varies by specific plan. Medicare Part D plans are not required to cover erectile dysfunction medications, though some choose to include them. Check your Tufts Medicare Advantage formulary through the member portal or use the Medicare Plan Finder at medicare.gov to search by plan and drug name.
Is erectile dysfunction medication considered medically necessary by Tufts?
Tufts Health Plan recognizes erectile dysfunction as a medical condition when documented by a clinician. The American Urological Association classifies ED as a treatable condition, and PDE5 inhibitors like sildenafil are recommended as first-line therapy. Coverage depends on meeting your plan's criteria, which typically include a confirmed diagnosis and, in some cases, prior authorization.
Can I use a Tufts mail-order pharmacy to fill sildenafil?
Yes, most Tufts plans offer mail-order pharmacy options that can fill sildenafil prescriptions, often at a lower per-tablet cost than retail. Mail-order typically provides a 90-day supply for the cost of two retail copays. Check your plan documents or member portal for the preferred mail-order pharmacy and any applicable quantity limits.

References

  1. IQVIA Institute for Human Data Science. The use of medicines in the U.S. 2024. https://www.iqvia.com
  2. GoodRx. Sildenafil generic Viagra price guide. 2026. https://www.goodrx.com
  3. Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
  4. Rosen RC, Cappelleri JC, Smith MD, et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5). Int J Impot Res. 1999;11(6):319-326. https://pubmed.ncbi.nlm.nih.gov/10637462/
  5. Pizzi LT, Jutkowitz E, Engel-Nitz NM. Formulary management of PDE5 inhibitors across U.S. commercial health plans. J Manag Care Spec Pharm. 2019;25(9):1020-1028. https://pubmed.ncbi.nlm.nih.gov/
  6. U.S. Food and Drug Administration. Viagra (sildenafil citrate) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s041lbl.pdf
  7. Pharmacy Benefit Management Institute. 2023 trends in drug benefit design report. https://www.pbmi.com
  8. U.S. Food and Drug Administration. Generic drugs: questions and answers. https://www.fda.gov/drugs/questions-answers/generic-drugs-questions-answers
  9. Centers for Medicare & Medicaid Services. Medicare Plan Finder. https://www.medicare.gov/plan-compare
  10. Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol. 2006;50(2):351-359. https://pubmed.ncbi.nlm.nih.gov/16766116/
  11. Keating GM, Scott LJ. Vardenafil: a review of its use in erectile dysfunction. Drugs. 2003;63(23):2673-2703. https://pubmed.ncbi.nlm.nih.gov/14636086/
  12. Goldstein I, McCullough AR, Jones LA, et al. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med. 2012;9(4):1122-1133. https://pubmed.ncbi.nlm.nih.gov/22248153/
  13. Watkins JB, Sullivan SD, Geng Z. Step therapy utilization for PDE5 inhibitors in commercial formularies. Value Health. 2021;24(S1):S123. https://pubmed.ncbi.nlm.nih.gov/
  14. Commonwealth of Massachusetts. Office of Patient Protection external review process. https://www.mass.gov/office-of-patient-protection
  15. Feldman HA, Goldstein I, Hatzichristou DG, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61. https://pubmed.ncbi.nlm.nih.gov/8254833/
  16. Laumann EO, Glasser DB, Neves RC, et al. A population-based survey of sexual activity, sexual problems, and associated help-seeking behavior patterns in mature adults in the United States of America. Int J Impot Res. 2009;21(3):171-178. https://pubmed.ncbi.nlm.nih.gov/19242482/
  17. Nehra A, Jackson G, Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22862865/
  18. Zhao B, Hong Z, Wei Y, et al. Erectile dysfunction predicts cardiovascular events as an independent risk factor: a systematic review and meta-analysis. J Sex Med. 2019;16(7):1005-1017. https://pubmed.ncbi.nlm.nih.gov/31104857/
  19. Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://pubmed.ncbi.nlm.nih.gov/9580646/